SCHEDULE 13G/A: BML Investment Partners and Leonard Braden Michael Disclose Significant Stake in Instil Bio, Inc.
Beneficial Ownership Report
BML Investment Partners, L.P. and Leonard Braden Michael have jointly disclosed a beneficial ownership of 6.74% in Instil Bio, Inc.'s common stock as of December 31, 2024.
Summary
- BML Investment Partners, L.P. and Leonard Braden Michael have filed an Amendment No. 1 to Schedule 13G, disclosing their beneficial ownership in Instil Bio, Inc. (CUSIP: 45783C101).
- As of December 31, 2024, the aggregate amount beneficially owned by the reporting persons is 440,000 shares of Instil Bio, Inc. common stock.
- This beneficial ownership represents 6.74% of the total outstanding common stock of Instil Bio, Inc.
- BML Investment Partners, L.P. is reported to have shared voting and dispositive power over 400,000 shares, representing 6.1% of the class.
- Leonard Braden Michael is reported to have sole voting and dispositive power over 40,000 shares, and shared voting and dispositive power over 400,000 shares, totaling 440,000 shares or 6.7% of the class.
- The filing certifies that the securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of Instil Bio, Inc.
Sentiment
Score: 5
Explanation: The document is a factual disclosure of beneficial ownership and does not contain information that would typically influence sentiment regarding the company's operational or financial performance.
Future Outlook
NA This document is a beneficial ownership report and does not contain forward-looking statements or guidance regarding the issuer's future performance.
Industry Context
A Schedule 13G filing indicates that an investor or group has acquired more than 5% of a company's stock, but without the intent to control or influence management. This type of filing is common for passive investors like mutual funds, pension funds, or individuals who hold a significant stake for investment purposes. It provides transparency regarding large ownership positions in publicly traded companies, signaling a significant investor's confidence in the company's long-term prospects.
Stakeholder Impact
- Shareholders: Provides transparency regarding significant ownership stakes, which can influence market perception of the stock's stability and investor confidence.
Key Dates
| Date | Description |
|---|---|
| 12/31/2024 | Date of event which requires filing of this statement |
| 02/13/2025 | Date of filing of this statement |
Keywords
Instil Bio, BML Investment Partners, Leonard Braden Michael, Schedule 13G, beneficial ownership, common stock, SEC filing, equity stake, investment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.